ArticleBlood2007

Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis.

Francisco M Marty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.